Ie Kenya, Aoshima Shuichi, Yabuki Taku, Albert Steven M
Division of General Internal Medicine Department of Internal Medicine St. Marianna University School of Medicine Kawasaki Japan.
Division of General Internal Medicine Department of Internal Medicine Kawasaki Municipal Tama Hospital Kawasaki Japan.
J Gen Fam Med. 2021 May 28;22(4):182-196. doi: 10.1002/jgf2.464. eCollection 2021 Jul.
Potentially inappropriate prescription and polypharmacy are well-known risk factors for morbidity and mortality among older adults. However, recent systematic reviews have failed to demonstrate the overall survival benefits of deprescribing. Thus, it is necessary to synthesize the current evidence to provide a practical direction for future research and clinical practice. This review summarizes the existing body of evidence regarding deprescribing to identify useful intervention elements. There is evidence that even simple interventions, such as direct deprescribing targeted at risky medications and explicit criteria-based approaches, effectively reduce inappropriate prescribing. On the other hand, if the goal is to improve clinical outcomes such as hospitalization and emergency department visits, patient-centered multimodal interventions such as a combination of medication review, multidisciplinary collaboration, and patient education are likely to be more effective. We also consider the opportunities and challenges for deprescribing within the Japanese healthcare system.
潜在不适当处方和多重用药是老年人发病和死亡的众所周知的风险因素。然而,最近的系统评价未能证明减药对总体生存的益处。因此,有必要综合当前证据,为未来研究和临床实践提供实用指导。本综述总结了关于减药的现有证据,以确定有用的干预要素。有证据表明,即使是简单的干预措施,如针对高风险药物的直接减药和基于明确标准的方法,也能有效减少不适当处方。另一方面,如果目标是改善住院和急诊就诊等临床结局,以患者为中心的多模式干预措施,如药物审查、多学科协作和患者教育相结合,可能会更有效。我们还考虑了日本医疗体系中减药的机遇和挑战。